Antony J. Mersiades
Frenches Forest
NSW, Australia
NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Real-world treatment sequencing and survival in ROS1-Rearranged NSCLC across evolving treatment eras: Findings from the AURORA multi-centre registry (AURORA-ROS1).
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 25, 2026
Genomic Therapy Matching in Rare and Refractory Cancers.
Journal: JAMA oncology
Published: March 05, 2026
Impact of PD-L1 on first-line osimertinib outcomes in EGFR-mutant NSCLC: real-world data from the AURORA25 study and meta-analysis.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: October 29, 2025
Durvalumab, Tremelimumab, and Platinum Chemotherapy in EGFR Mutation-Positive NSCLC: An Open-Label Phase 2 Trial (ILLUMINATE).
Journal: JTO clinical and research reports
Published: September 18, 2024
Oral Cannabis Extract for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting: Final Results of a Randomized, Placebo-Controlled, Phase II/III Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 16, 2024
ALKTERNATE: A Pilot Study Alternating Lorlatinib With Crizotinib in ALK-Positive NSCLC With Prior ALK Inhibitor Resistance.
Journal: JTO clinical and research reports
Published: March 04, 2024
First-line chemoimmunotherapy and immunotherapy in patients with non-small cell lung cancer and brain metastases: a registry study.
Journal: Frontiers in oncology
Published: October 02, 2023
ASPiRATION: Australian observational cohort study of comprehensive genomic profiling in metastatic lung cancer tissue.
Journal: Future oncology (London, England)
Published: September 28, 2023
A Phase II trial of alternating osimertinib and gefitinib therapy in advanced EGFR-T790M positive non-small cell lung cancer: OSCILLATE.
Journal: Nature communications
Published: July 06, 2023
Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: June 13, 2020
Medicinal cannabis for chemotherapy-induced nausea and vomiting: prescribing with limited evidence.
Journal: The Medical journal of Australia
Published: January 14, 2019
Showing 1-12 of 12
Last Updated: 09/26/2026